Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Head and Neck Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06494189
What this trial is testing

Low-dose Radiotherapy Plus Tislelizumab in Combination With Afatinib for Neoadjuvant Treatment of Surgically Resectable Head and Neck Squamous Carcinoma

Who this might be right for
Head and Neck Cancer
West China Hospital 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07705074
What this trial is testing

FAPI PET Imaging - An Exploratory Study

Who this might be right for
Thyroid PathologyHead and Neck Cancer (H&N)Sinonasal Tract Tumor+14 more
Martin Huellner 770
Not applicableLooking for participantsNCT05231655
What this trial is testing

Ex VIvo DEtermiNed Cancer Therapy

Who this might be right for
Bladder CancerKidney CancerMelanoma+3 more
Sheffield Teaching Hospitals NHS Foundation Trust 600
Not applicableActive Not RecruitingNCT04251481
What this trial is testing

Diffusion MRI for Head and Neck Cancer

Who this might be right for
Head Cancer Neck
NYU Langone Health 16
Not applicableNot Yet RecruitingNCT07622407
What this trial is testing

Maximizing Quality of Life After Cancer Through Rehabilitation

Who this might be right for
Head and Neck CancerHearing LossTinnitus+1 more
VA Office of Research and Development 74
Not applicableNot Yet RecruitingNCT07786155
What this trial is testing

Effect of a Multimodal Antiemetic Protocol on Postoperative Nausea and Vomiting in Patients Undergoing Flap Surgery for Head and Neck Cancer

Who this might be right for
Postoperative Nausea and Vomiting
Seoul National University Hospital 72
Testing effectiveness (Phase 2)UnknownNCT03771820
What this trial is testing

Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen

Who this might be right for
SCCHN
NanoCarrier Co., Ltd. 136
Testing effectiveness (Phase 2)Looking for participantsNCT04988074
What this trial is testing

Trial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca

Who this might be right for
HPV-Related Squamous Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 32
Not applicableWithdrawnNCT00372450
What this trial is testing

Plastic Stents Compared With Metal Stents in Treating Patients With Malignant Dysphagia Caused by Esophageal Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal CancerGastrointestinal Complications
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT00003443
What this trial is testing

Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT00615420
What this trial is testing

Placebo-Controlled Trial of Manuka Honey for Oral Mucositis Due to Radiation Therapy for Cancer

Who this might be right for
Radiotherapy Induced MucositisHead and Neck Cancer
British Columbia Cancer Agency 106
Testing effectiveness (Phase 2)Ended earlyNCT02842125
What this trial is testing

Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell Cancer

Who this might be right for
Metastatic Solid Tumor CancerRecurrent Head and Neck Cancer
MultiVir, Inc. 4
Testing effectiveness (Phase 2)UnknownNCT03146650
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Metastatic/Recurrent ACC of All Sites and Non-ACC Salivary Gland Cancer

Who this might be right for
Major Salivary Gland CarcinomaMinor Salivary Gland CarcinomaRecurrent Salivary Gland Carcinoma+4 more
Northwestern University 25
Testing effectiveness (Phase 2)UnknownNCT03024489
What this trial is testing

Palbociclib With Cetuximab and IMRT for Locally Advanced Squamous Cell Carcinoma

Who this might be right for
Head and Neck CancerLocally Advanced
Mahidol University 27
Not applicableActive Not RecruitingNCT05179824
What this trial is testing

Tempus Priority Study: A Pan-tumor Observational Study

Who this might be right for
Breast CancerProstate CancerBladder Cancer+24 more
Tempus AI 1,000
Not applicableStudy completedNCT00068497
What this trial is testing

Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer

Who this might be right for
Anaplastic Thyroid CancerInsular Thyroid CancerMetastatic Parathyroid Cancer+83 more
National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)Study completedNCT00656513
What this trial is testing

Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerXerostomia
Radiation Therapy Oncology Group 196
Not applicableStudy completedNCT04636723
What this trial is testing

Neuroinflammation in Chronic Systemic Symptoms (CSS)

Who this might be right for
CancerCancer Head NeckNeuroinflammatory Response+3 more
Vanderbilt University Medical Center 30
Not applicableNot Yet RecruitingNCT07732686
What this trial is testing

Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry

Who this might be right for
Pancreas CancerHepatocellular CarcinomaLung Cancer+6 more
University of Oklahoma 2,000
Testing effectiveness (Phase 2)Study completedNCT03418480
What this trial is testing

HARE-40: HPV Anti-CD40 RNA vaccinE

Who this might be right for
Human Papilloma Virus Related CarcinomaHead and Neck NeoplasmCervical Neoplasm+2 more
University of Southampton 32
Next Page